All updated as on -
During the projected period (2024-2031), the naloxone market is expected to increase at a CAGR of 13.1%. From 2023 to 2024, the market was worth 850.07 million USD, 940.64 million USD, and 2,178.85 million USD by 2031, according to projections.
Overdoses of opioids, such as heroin, fentanyl, and prescription opioids, can be reversed with the use of naloxone if administered promptly. Another name for it is Narcan. Naloxone can bring about a return to normal respiration and awareness by obstructing the effects of opioids on the brain. With no room for abuse, naloxone is both effective and safe.
Several versions of naloxone are on the market, including nasal spray, oral, and injectable. Many pharmacies, health departments, and community groups provide naloxone to those in need. Many pharmacies stock naloxone, and it's also supplied frequently by health departments and community groups. The availability of naloxone has been enhanced, leading to a surge in demand.
Businesses in every industry, including private healthcare, have felt the effects of the global COVID-19 outbreak and subsequent lockdowns. The widespread use of lockdown measures in response to the COVID-19 pandemic has had a profound effect on the healthcare industry's supply chain. Regional economies around the world have felt the effects of the COVID-19 pandemic in three key ways: first, the supply and demand for healthcare items has been hit hard; second, distribution systems have been disrupted; and third, companies and markets have taken a financial hit.
There are issues with the distribution and delivery of healthcare supplies in a number of nations, including Singapore, Indonesia, and Thailand. The COVID-19 epidemic had a significant effect on the naloxone market since fewer people were getting their prescriptions filled for the drug.As an example, a May 2021 article in the Healio Journal stated that during the COVID-19 pandemic, the number of completed naloxone prescriptions dropped more precipitously than the number of filled opioid prescriptions or any other medicine.
Overdosing on opioids can be fatal unless the medicine naloxone is administered. It binds to opioid receptors and prevents other opioids like oxycodone and morphine from having an impact. This makes it an opioid antagonist. The number of fatal overdoses in the US has reached an all-time high due to the opioid crisis. More than 100,000 Americans lost their lives to drug overdoses in 2021, with opioids being the leading cause of death, according to a report from the National Institutes of Health. Since no other medicine has been found to reverse an opioid overdose, this has led to a high demand for naloxone.
In addition, the opioid pandemic has become much more lethal due to the introduction of fentanyl. It is common practice to combine fentanyl, a potent synthetic opioid, with heroin and prescription opiates. It is easier to overdose on because of its extreme potency compared to heroin or morphine. Since reversing a fentanyl overdose may need numerous doses of naloxone, its use has grown in recent years. As a result, naloxone is in high demand around the world due to the rising number of opioid overdose occurrences.
Some individuals who really need naloxone are unable to get their hands on it because of how expensive it is. The opioid crisis is having a disproportionate effect on minority and low-income neighborhoods, so this is very worrisome. The final cost of naloxone around the globe is significantly increased by the high manufacturing cost, restricted competition, and other factors. The production of naloxone is a highly specialized industry. Price increases may result from an absence of alternatives. The manufacturing process for naloxone is subject to stringent regulatory restrictions, which adds to the complexity of the medication and ultimately drives up its cost.
Report Coverage
Global Naloxone research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Naloxone report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Naloxone competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Naloxone market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Naloxone market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Naloxone market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Viatris Inc., Opiant Pharmaceuticals, Akorn Operating Company LLC, Pfizer, Inc., Novartis AG, Indivior Plc., Emergent BioSolutions Inc., Amphastar Pharmaceuticals, Inc., Kern Pharma, S.L., Hikma Pharmaceuticals PLC, Mundipharma International Limited, and Kaleo, Inc.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Naloxone market based on the below-mentioned segments:
Global Naloxone Market, By Type
Injectable Naloxone
Intranasal Naloxone
Global Naloxone market, By Application
Opioid Overdose Reversal
Chronic Pain Management
Global Naloxone Market, By End User
Hospitals
Ambulatory Surgical Centers
Rehabilitation Centers
Global Naloxone market, Regional Analysis
Overdoses of opioids, such as heroin, fentanyl, and prescription opioids, can be reversed with the use of naloxone if administered promptly. Another name for it is Narcan. Naloxone can bring about a return to normal respiration and awareness by obstructing the effects of opioids on the brain. With no room for abuse, naloxone is both effective and safe.
Several versions of naloxone are on the market, including nasal spray, oral, and injectable. Many pharmacies, health departments, and community groups provide naloxone to those in need. Many pharmacies stock naloxone, and it's also supplied frequently by health departments and community groups. The availability of naloxone has been enhanced, leading to a surge in demand.
Businesses in every industry, including private healthcare, have felt the effects of the global COVID-19 outbreak and subsequent lockdowns. The widespread use of lockdown measures in response to the COVID-19 pandemic has had a profound effect on the healthcare industry's supply chain. Regional economies around the world have felt the effects of the COVID-19 pandemic in three key ways: first, the supply and demand for healthcare items has been hit hard; second, distribution systems have been disrupted; and third, companies and markets have taken a financial hit.
There are issues with the distribution and delivery of healthcare supplies in a number of nations, including Singapore, Indonesia, and Thailand. The COVID-19 epidemic had a significant effect on the naloxone market since fewer people were getting their prescriptions filled for the drug.As an example, a May 2021 article in the Healio Journal stated that during the COVID-19 pandemic, the number of completed naloxone prescriptions dropped more precipitously than the number of filled opioid prescriptions or any other medicine.
Overdosing on opioids can be fatal unless the medicine naloxone is administered. It binds to opioid receptors and prevents other opioids like oxycodone and morphine from having an impact. This makes it an opioid antagonist. The number of fatal overdoses in the US has reached an all-time high due to the opioid crisis. More than 100,000 Americans lost their lives to drug overdoses in 2021, with opioids being the leading cause of death, according to a report from the National Institutes of Health. Since no other medicine has been found to reverse an opioid overdose, this has led to a high demand for naloxone.
In addition, the opioid pandemic has become much more lethal due to the introduction of fentanyl. It is common practice to combine fentanyl, a potent synthetic opioid, with heroin and prescription opiates. It is easier to overdose on because of its extreme potency compared to heroin or morphine. Since reversing a fentanyl overdose may need numerous doses of naloxone, its use has grown in recent years. As a result, naloxone is in high demand around the world due to the rising number of opioid overdose occurrences.
Some individuals who really need naloxone are unable to get their hands on it because of how expensive it is. The opioid crisis is having a disproportionate effect on minority and low-income neighborhoods, so this is very worrisome. The final cost of naloxone around the globe is significantly increased by the high manufacturing cost, restricted competition, and other factors. The production of naloxone is a highly specialized industry. Price increases may result from an absence of alternatives. The manufacturing process for naloxone is subject to stringent regulatory restrictions, which adds to the complexity of the medication and ultimately drives up its cost.
Report Coverage
Global Naloxone research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Naloxone report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Naloxone competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Naloxone market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Viatris Inc., Opiant Pharmaceuticals, Akorn Operating Company LLC, Pfizer, Inc., Novartis AG, Indivior Plc., Emergent BioSolutions Inc., Amphastar Pharmaceuticals, Inc., Kern Pharma, S.L., Hikma Pharmaceuticals PLC, Mundipharma International Limited, and Kaleo, Inc. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Naloxone Market from 2021 to 2031.
- Market Forecast for Naloxone Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Naloxone competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Naloxone
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Naloxone market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Naloxone market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Viatris Inc., Opiant Pharmaceuticals, Akorn Operating Company LLC, Pfizer, Inc., Novartis AG, Indivior Plc., Emergent BioSolutions Inc., Amphastar Pharmaceuticals, Inc., Kern Pharma, S.L., Hikma Pharmaceuticals PLC, Mundipharma International Limited, and Kaleo, Inc.
Primary Target Market
- Market Players of Naloxone
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Naloxone market based on the below-mentioned segments:
Global Naloxone Market, By Type
Injectable Naloxone
Intranasal Naloxone
Global Naloxone market, By Application
Opioid Overdose Reversal
Chronic Pain Management
Global Naloxone Market, By End User
Hospitals
Ambulatory Surgical Centers
Rehabilitation Centers
Global Naloxone market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive naloxone market market research and competitor analysis for your business to help you develop more profound insights into the naloxone market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the naloxone market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.